Kathryn Jordan

Kathryn Jordan is an accomplished scientist with comprehensive experience in the biomedical engineering field. Currently serving as a Scientist at GSK since February 2023 and as a Senior Associate Scientist at Affinivax Inc. since January 2022, Kathryn specializes in vaccine discovery, immunology assay development, and in vivo studies in rodents. Previous roles include Associate Engineer and Associate Scientist at Sigilon Therapeutics, where Kathryn focused on 3D-bioprinting and preclinical in vivo studies. Kathryn's foundational experiences as a Research Technician at Tufts University involved biomaterial fabrication and mentoring students in biomedical projects. Educationally, Kathryn holds a Master of Science in Biomedical Engineering from Tufts University and a Bachelor of Science in Biomedical Engineering from Western New England University.